Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co ElifiledCriticalLilly Co Eli
Publication of MY132585ApublicationCriticalpatent/MY132585A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Furan Compounds
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
COMPOUNDS FOR FORMULA I@@(FORMULA 1)@@IN WHICH X REPRESENTS O, NRA, S, SO OR SO2 AND R IS AS DEFINED IN THE SPECIFICATION; AND NON-TOXIC METABOLICALLY LABILE ESTERS OR AMIDES THEREOF; AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF ARE USEFUL AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR FUNCTION.
Mono-n-substituted 1,4,7,10-tetraazacyclododecane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
Novel branched substituted amino derivatives of 3-amino-1-phenyl-1H-Ä1,2,4Ütriazol, methods for producing them and pharmaceutical compositions containing them